Statera Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q4 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Statera Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2019 to Q3 2022.
  • Statera Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2022 was $1.4M, a 1.69% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $1.4M +$23.3K +1.69% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.58M Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $1.71M Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $1.54M Dec 31, 2021 10-K 2022-10-06
Q3 2021 $1.38M Sep 30, 2021 10-Q 2021-11-15
Q4 2019 $7.31K Dec 31, 2019 10-K 2020-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.